IP & Royalty Tax Planning

IP & Royalty Tax Planning Hong Kong

Hong Kong's FSIE regime and preferential IP tax treatment make it an attractive location for IP holding — if structured correctly with adequate substance. Get the IP structure right before BEPS rules catch up with you.

HKICPA登録済み 24時間対応 固定料金制 100%秘密厳守
無料相談を受ける
5% Concessionary tax rate for qualifying IP
0% WHT on royalties paid to HK company
2023 FSIE regime effective year

IP & Royalty Tax Planning

Hong Kong's FSIE regime and preferential IP tax treatment make it an attractive location for IP holding — if structured correctly with adequate substance. Get the IP structure right before BEPS rules catch up with you.

⚠️

⚠ Post-BEPS IP Structures Require Real Substance

The OECD modified nexus approach requires IP income to be linked to IP development expenditure in the same jurisdiction. "Brass plate" IP holding in HK without genuine R&D or development activity will fail the modified nexus test under the 2024 patent box rules.

よくあるお悩み

以下の税務問題でお困りではありませんか？

Modified Nexus Approach

Under HK's patent box (effective 2024), the concessionary 5% rate only applies to the proportion of IP income matching qualifying R&D expenditure incurred in HK.

⚠ Risk: Outsourced R&D reduces nexus fraction → higher effective rate

Royalty Withholding Tax

Royalties received from overseas payors may be subject to WHT in the payor country. HK's DTA network can reduce this — but only if the HK IP company has substance.

⚠ Risk: No DTA access → full withholding tax reduces royalty income

FSIE Passive Income Rules

From 2023, IP income received by HK companies from foreign sources is subject to FSIE — taxable unless the nexus condition or participation exemption applies.

⚠ Risk: No nexus planning → IP income brought into HK charge unexpectedly

Royalty Rate Setting

Intercompany royalty rates between the HK IP company and operating subsidiaries must be arm's length under HK TP rules.

⚠ Risk: Above-market royalty → IRD disallows deduction in HK subsidiary
対象者

対象となるお客様

Tech companies with HK IP holding

Software, SaaS, and technology companies holding patents, trademarks, or source code in HK.

Pharmaceutical and biotech groups

Life sciences companies with drug patents or clinical data held in HK entities.

Media and content companies

Companies holding copyrights, trademarks, or brands through HK holding vehicles.

Manufacturing groups

Groups licensing production know-how or process patents from a HK IP company to overseas factories.

サービス内容

サービス内容

IP Holding Structure Design

Design the optimal IP holding structure — pure HK, HK + offshore layer, or integrated opco/holdco — based on the type of IP, users, and FSIE/nexus requirements.

BEPS-compliant substance planning included

Patent Box Analysis

Calculate the qualifying fraction of IP income eligible for HK's 5% concessionary rate and plan R&D expenditure to maximise the fraction.

Per IRO s.20I–20N (proposed provisions)

IP Licence Agreement Review

Review intercompany IP licence agreements for arm's length royalty rates, proper BEPS-compliant DEMPE function analysis, and TP documentation.

DEMPE = development, enhancement, maintenance, protection, exploitation

WHT Reduction Planning

Map royalty payment flows against HK's DTA network to minimise withholding tax in payor jurisdictions.

Substance requirements for DTA access
ご利用の流れ

シンプル・効率的・プロフェッショナル

1

IP Asset Inventory

Map all IP assets, their legal owners, economic owners (DEMPE functions), and royalty flows.

1-2 weeks
2

Structure Analysis

Assess current structure against FSIE, nexus, and TP requirements.

1-2 weeks
3

Restructuring Plan

Design and implement optimal IP holding structure with substance plan.

4-8 weeks
4

Annual Compliance

Maintain nexus tracking, TP documentation, and FSIE filings annually.

Annual
ご相談はお気軽に 義務なし・キャンセル自由
無料相談を予約する
お客様の成功事例

実際のクライアントへの実績

Case Study

Software company — HK IP holding restructure

HKD 1,600,000 節約額
  • Source code and patents transferred to HK IP company
  • Patent box analysis: 72% qualifying fraction
  • Effective IP tax rate reduced from 16.5% to 7.2%
  • Substance plan: 3 HK R&D staff added
"We didn't realise how much HK's IP regime could save us until they ran the numbers."
C
確認済みクライアント Case Study
Case Study

Pharmaceutical group — royalty WHT reduction

HKD 2,100,000 節約額
  • Royalties from 5 Asian jurisdictions consolidated via HK IP company
  • DTA access confirmed with substance analysis
  • WHT reduced from 10-15% to 0-5% per treaty
  • Annual royalty income HKD 28M
"The substance investment paid back in 8 months from WHT savings alone."
C
確認済みクライアント Case Study
★★★★★ 2,400+ 名以上のお客様にご信頼いただいています
無料相談を受ける

無料専門家相談

今すぐシニア税務専門家にご相談ください

  • 30分間の無料初回相談
  • シニアCPAが担当いたします
  • 義務なし・キャンセル自由
HKICPA 登録 24時間以内に返答 義務なし

お客様の情報は厳重に秘密保持されます。

選ばれる理由

TAX.hk を選ぶ理由

香港税務の深い専門知識

当社の公認会計士は15年以上の香港税務経験を有し、税務局の最新情報を常に把握しています。

透明な固定料金

時間単位の請求による予期せぬ費用はありません。開始前に費用を明確にご提示します。

24時間以内の回答

すべてのお問い合わせに1営業日以内にご返答します。緊急案件は4時間以内に対応いたします。

厳格な秘密保持

すべてのお客様情報は、厳格な職業上の守秘義務に基づき管理されています。

よくある質問

よくある質問

ご質問への迅速な回答

HK introduced a patent box regime (effective from year of assessment 2023/24) under which profits derived from qualifying IP assets (patents, plant variety rights, copyright in software) are taxed at a preferential 5% rate (vs standard 16.5%) — but only on the proportion matching R&D expenditure incurred in HK under the modified nexus approach.
Qualifying IP income includes royalties, licensing fees, embedded IP income in product sales (if separately identifiable), and gains from IP disposal. Brand income (trademarks) does NOT qualify under HK's patent box. Only patents, copyrighted software, and plant variety rights qualify.
From 1 January 2023, specified foreign-source passive income (dividends, interest, disposal gains, and IP income) received by HK companies is taxable in HK unless an exemption applies. For IP income, the exemption requires the HK entity to satisfy the economic substance or nexus requirements.
Post-BEPS, an IP holding company needs: (1) adequate employees with relevant skills in HK, (2) meaningful R&D or DEMPE activities conducted in HK or by qualifying contract R&D, (3) management and control in HK, and (4) arm's length royalty arrangements. "Brass plate" structures no longer work.
DEMPE stands for Development, Enhancement, Maintenance, Protection, and Exploitation of IP. Under BEPS Action 8-10, the right to IP income follows the entity performing DEMPE functions with substance — not legal ownership. A HK IP company must perform meaningful DEMPE functions to justify its IP income allocation.
Royalty rates must be arm's length — comparable to what unrelated parties would agree for the same IP under similar conditions. Benchmarking methods include the CUP method (if comparable licenses exist), the profit split method, or the residual profit split. We conduct a formal TP benchmarking study to set and defend the rate.

ご相談はお気軽に

香港の上級税務専門家との無料相談を今すぐご予約ください。

無料相談を予約する 担当コンサルタントを見る
その他のサービス

関連サービス

R&D Tax Incentives Companies with R&D Expenditure in Hong Kong
FSIE Regime Specialist MNE Groups with HK Passive Income Structures
Related Party Transaction Tax Companies with Intercompany & Related Party Dealings
BEPS Pillar Two Compliance Large MNC Groups with HK Operations Above EUR 750M Threshold

このページは一般的な情報提供を目的としています。お客様の具体的な状況に応じたアドバイスについては、資格を持つ香港の税務専門家にご相談ください。